Exploring the Current Digital Health M&A Landscape: Challenges & Opportunities in Getting Deals Done

Oct. 13, 2022
1:00 pm - 2:00 pm

About This Event

As the Digital Health sector matures, companies are looking to consolidate through partnership and integration, while focusing on building stronger relationships between patients and providers, offering easier access to care, and delivering a more personalized healthcare experience. Strong VC funding in emerging companies has created a fertile environment for new and disruptive technologies for buyers.

After a strong 2021 for M&A in the healthcare sector, 2022 has seen a dramatic downturn in deal activity as the economy slowed, inflation and interest rates rose, global supply chain issues continued, and the Russia-Ukraine war began. With the slowdown, the year’s biggest healthcare deals have focused on acquiring digital capabilities, such as digital care and cloud-based platforms, and Digital Health deal makers are likely to continue to focus on revenue and operational synergies.

Will we continue to see more consolidations that have dominated the market recently? Will more conglomerates enter the market to unlock value? How will rising interest rates, inflation, supply chain concerns, and geopolitical issues impact valuations? In a post-Covid remote world, how are dealmakers adjusting to performing due diligence and post-transaction integration? How is intellectual property and the use of data playing into the Digital Health M&A landscape?

Join us on October 13th at 1:00pm Eastern as The Deal along with global law firm Pillsbury Winthrop Shaw Pittman LLP hosts a roundtable of leading Digital Health M&A dealmakers exploring the digital transformation of the industry.

Speakers

MODERATOR
Ronald Fleming, Partner, Pillsbury

Ron, the leader of Pillsbury’s Emerging Companies team in New York, maintains a broad-based corporate practice that encompasses securities offerings and compliance, venture capital, mergers and acquisitions, and general corporate law. He also focuses on emerging private and public companies and the technology, biotechnology and telecommunications industries.

Read Bio
Rebecca Messing Haigler
Director, OneFifteen CA; Verily Life Sciences
Read Bio
Ted Powers
Partner, Pillsbury
Read Bio
Arjun Sethi
Co-Founder and Partner, Tribe Capital
Read Bio
Gary Sheehan
Senior Vice President, AdaptHealth
Read Bio
Katherine Wood
Partner, TPG
Read Bio

Contact Us

Please contact us for general inquiries.

Sponsors

More Upcoming Events

Mar
7
ESG

The Deal's ESG & Sustainability Forum

8:00 am - 6:30 pm

ESG and Sustainability concerns are now playing a prominent role in how companies around the world operate, and how investors allocate their capital.